Skip to main content

Measles vaccine immune escape: Should we be concerned?

European Journal of Epidemiology volume 34, pages 893–896 (2019)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL. Measles. Nat Rev Dis Primers. 2016;14(2):16049.

    Article  Google Scholar 

  2. Measles. [cited 2019 Oct 20]. https://www.who.int/news-room/fact-sheets/detail/measles.

  3. Mina MJ, Metcalf CJE, de Swart RL, Osterhaus ADME, Grenfell BT. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science. 2015;348(6235):694–9.

    CAS  Article  Google Scholar 

  4. Mina MJ, Kula T, Leng Y, Li M, de Vries RD, Knip M, et al. Measles virus infection diminishes preexisting antibodies that offer protection from otherpathogens. Science. 2019;366(6465):599–606.

    CAS  Article  Google Scholar 

  5. Moss WJ, Griffin DE. Global measles elimination. Nat Rev Microbiol. 2006;4:900–8.

    CAS  Article  Google Scholar 

  6. Strebel PM, Henao-Restrepo A-M, Hoekstra E, Olivé J-M, Cochi SL. Global measles elimination efforts: the significance of measles elimination in the United States. J Infect Dis. 2004;189:S251–7.

    Article  Google Scholar 

  7. Measles Elimination in the U.S. | CDC. 2019 [cited 2019 Oct 20]. https://www.cdc.gov/measles/elimination.html.

  8. Metcalf CJE, Ferrari M, Graham AL, Grenfell BT. Understanding herd immunity. Trends Immunol. 2015;36:753–5.

    CAS  Article  Google Scholar 

  9. Javelle E, Colson P, Parola P, Raoult D. Measles, the need for a paradigm shift. Eur J Epidemiol. 2019. https://doi.org/10.1007/s10654-019-00569-4.

    Article  PubMed  Google Scholar 

  10. Fatemi Nasab GS, Salimi V, Abbasi S, Adjami Nezhad Fard F, Mokhtari Azad T. Comparison of neutralizing antibody titers against outbreak-associated measles genotypes (D4, H1 and B3) in Iran. Pathog Dis. 2016;74(8):089.

    Article  Google Scholar 

  11. Dascalu S. Measles epidemics in romania: lessons for public health and future policy. Front Public Health. 2019;25(7):98.

    Article  Google Scholar 

  12. Ciceri G, Canuti M, Bianchi S, Gori M, Piralla A, Colzani D, et al. Genetic variability of the measles virus hemagglutinin gene in B3 genotype strains circulating in Northern Italy. Infect Genet Evol. 2019;28(75):103943.

    Article  Google Scholar 

  13. Kurchatova A, Krumova S, Vladimirova N, Nikolaeva-Glomb L, Stoyanova A, Kantardjiev T, et al. Preliminary findings indicate nosocomial transmission and Roma population as most affected group in ongoing measles B3 genotype outbreak in Bulgaria, March to August 2017. Eurosurveillance. 2017;22:30611.

    Article  Google Scholar 

  14. Lochlainn LN, Mandal S, de Sousa R, Paranthaman K, van Binnendijk R, Ramsay M, et al. A unique measles B3 cluster in the United Kingdom and the Netherlands linked to air travel and transit at a large international airport, February to April 2014. Eurosurveillance. 2016;21:30177.

    Article  Google Scholar 

  15. Chiem AT. Infectious disease/CDC update. Measles Outbreak-California, December 2014–February 2015. Ann Emerg Med. 2015;66(1):82–3.

    Article  Google Scholar 

  16. Brown KE, Rota PA, Goodson JL, Williams D, Abernathy E, Takeda M, et al. Genetic characterization of measles and rubella viruses detected through global measles and rubella elimination surveillance, 2016–2018. MMWR. 2019;68:587–91.

    PubMed  Google Scholar 

  17. Harriman K. NVAC meeting [cited 2019 Oct 21]. https://www.hhs.gov/sites/default/files/nvpo/nvac/meetings/pastmeetings/2015/2014-2015_california_measles_outbreak.pdf.

  18. Takashima Y, Schluter WW, Mariano KML, Diorditsa S, de Quiroz Castro M, Ou AC, et al. Progress toward measles elimination—Philippines, 1998–2014. MMWR. 2015;64(13):357–62.

    PubMed  Google Scholar 

  19. World Health Organization. MeaNS—measles nucleotide surveillance. [cited 2019 Oct 19]. http://www.who-measles.org/Public/Web_Front/main.php.

  20. Patel MK, Orenstein WA. Classification of global measles cases in 2013–17 as due to policy or vaccination failure: a retrospective review of global surveillance data. Lancet Glob Health. 2019;7:e313–20.

    Article  Google Scholar 

  21. Ackley SF, Hacker JK, Enanoria WTA, Worden L, Blumberg S, Porco TC, et al. Genotype-specific measles transmissibility: a branching process analysis. Clin Infect Dis. 2018;66(8):1270–5.

    Article  Google Scholar 

  22. Hahné SJM, Nic Lochlainn LM, van Burgel ND, Kerkhof J, Sane J, Yap KB, et al. Measles outbreak among previously immunized healthcare workers, the Netherlands, 2014. J Infect Dis. 2016;214(12):1980–6.

    Article  Google Scholar 

  23. Gandon S, Mackinnon MJ, Nee S, Read AF. Imperfect vaccines and the evolution of pathogen virulence. Nature. 2001;414(6865):751–6.

    CAS  Article  Google Scholar 

  24. Lewnard JA, Grad YH. Vaccine waning and mumps re-emergence in the United States. Sci Transl Med. 2018;10(433):eaao5945.

    Article  Google Scholar 

  25. Kanjilal S, Mina MJ. Passive immunity for the treatment of influenza: quality not quantity. Lancet Respir Med. 2019;7:922–3.

    Article  Google Scholar 

  26. Xu GJ, Kula T, Xu Q, Li MZ, Vernon SD, Ndung’u T, et al. Comprehensive serological profiling of human populations using a synthetic human virome. Science. 2015;348(6239):aaa0698.

    Article  Google Scholar 

Download references

Funding

This work was funded by the National Institutes of Health (DP5-OD028145 to MJM and a Fogarty International Center Grant to BTG).

Author information

Authors and Affiliations

  1. Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA

    Luojun Yang & Bryan T. Grenfell

  2. Fogarty International Center, National Institutes of Health, Bethesda, MD, USA

    Bryan T. Grenfell

  3. Center for Communicable Disease Dynamics, Department of Epidemiology, Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA, USA

    Michael J. Mina

  4. Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

    Michael J. Mina

Authors
  1. Luojun Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bryan T. Grenfell
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael J. Mina
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributing equally to this work.

Corresponding author

Correspondence to Michael J. Mina.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yang, L., Grenfell, B.T. & Mina, M.J. Measles vaccine immune escape: Should we be concerned?. Eur J Epidemiol 34, 893–896 (2019). https://doi.org/10.1007/s10654-019-00574-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-019-00574-7